Pharmacological characterization of the discriminative stimulus effects of the potassium channel blocker 4-aminopyridine in rats.
暂无分享,去创建一个
[1] J. Barrett,et al. Attenuation of the locomotor activating effects of D-amphetamine, cocaine, and scopolamine by potassium channel modulators , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[2] L. Schechter. The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices. , 1997, Journal of Pharmacology and Experimental Therapeutics.
[3] J. Vry,et al. Stimulus properties of the L—type calcium channel agonist BAY k 8644 in rats , 1996, Behavioural pharmacology.
[4] C. Routledge,et al. Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5‐HT in the striatum of conscious rats , 1995, British journal of pharmacology.
[5] J. Barrett,et al. K-Channel blockers attenuate the presynaptic effects of the D2 D3 agonist quinpirole in monkeys , 1995, Pharmacology Biochemistry and Behavior.
[6] L. Schrama,et al. 4-Aminopyridine differentially affects the spontaneous release of radiolabelled transmitters from rat brain slices in vitro , 1995, Brain Research.
[7] Randolph M. Johnson,et al. Linopirdine (DuP 996) improves performance in several tests of learning and memory by modulation of cholinergic neurotransmission , 1994, Pharmacology Biochemistry and Behavior.
[8] E. Wong,et al. Cholinergic agents and delay-dependent performance in the rat , 1994, Pharmacology Biochemistry and Behavior.
[9] A. Brown,et al. Function and structure of voltage‐dependent potassium channels , 1994 .
[10] G A Gutman,et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. , 1994, Molecular pharmacology.
[11] S. Yoshida,et al. Antiamnesic and cholinomimetic side-effects of the cholinesterase inhibitors, physostigmine, tacrine and NIK-247 in rats. , 1993, European journal of pharmacology.
[12] T. Zetterström,et al. Quinine and 4-aminopyridine inhibit the stimulatory output of dopamine in nucleus accumbens and the behavioural activity produced by morphine. , 1993, European journal of pharmacology.
[13] A. Nordberg,et al. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[14] R. Tapia,et al. NMDA receptor antagonists protect against seizures and wet-dog shakes induced by 4-aminopyridine. , 1992, European journal of pharmacology.
[15] B. Fredholm,et al. 4‐Aminopyridine‐induced increase in basal and stimulation‐evoked [3H]‐NA release in slices from rat hippocampus: Ca2+ sensitivity and presynaptic control , 1991, British journal of pharmacology.
[16] M. Häusser,et al. Activation by cromakalim of pre- and post-synaptic ATP-sensitive K+ channels in substantia nigra. , 1991, Biochemical and biophysical research communications.
[17] A. Hunter,et al. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro , 1989, British journal of pharmacology.
[18] J. C. Stoof,et al. Restricted usefulness of tetraethylammonium and 4‐aminopyridine for the characterization of receptor‐operated K+ ‐channels , 1989, British journal of pharmacology.
[19] B. Rudy,et al. Diversity and ubiquity of K channels , 1988, Neuroscience.
[20] G. Damsma,et al. Differential effects of 4-aminopyridine and 2,4-diaminopyridine on the in vivo release of acetylcholine and dopamine in freely moving rats measured by intrastriatal dialysis. , 1988, European journal of pharmacology.
[21] Kitzman Jv,et al. Antagonism of xylazine sedation by 4-aminopyridine and yohimbine in cattle. , 1982 .
[22] T. Narahashi,et al. 3,4-diaminopyridine. A potent new potassium channel blocker. , 1978, Biophysical journal.
[23] T. Narahashi,et al. Dynamics of aminopyridine block of potassium channels in squid axon membrane , 1976, The Journal of general physiology.
[24] M. Rogawski,et al. Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-K(alpha) and pandinustoxin-K(alpha). , 1999, Epilepsy research.
[25] A. Mathie,et al. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. , 1998, General pharmacology.
[26] R. Hoffman,et al. Characterization of 4-aminopyridine in overdose. , 1994, Journal of Toxicology Clinical Toxicology.
[27] C. L. Cramer,et al. Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. , 1994, Life sciences.
[28] P. Lavoie,et al. Mechanism of aminopyridine-induced release of [3H]dopamine from rat brain synaptosomes. , 1991, General pharmacology.
[29] H. Kuriyama,et al. Pinacidil opens the ATP-sensitive and Ca-dependent K channel in smooth muscle cells of the rat and rabbit portal veins , 1990 .
[30] N. S. Cook,et al. The pharmacology of potassium channels and their therapeutic potential. , 1988, Trends in pharmacological sciences.
[31] Laura Gladstein,et al. Preliminary analysis of the discriminative stimuli induced by the calcium channel “agonist” BAY K 8644 , 1987 .
[32] B. Wallner,et al. Antagonism of xylazine sedation by 4-aminopyridine and yohimbine in cattle. , 1982, American journal of veterinary research.
[33] W. E. Glover. The aminopyridines. , 1982, General pharmacology.